SGS’s N.J. facility undergoes major expansion

Tuesday, September 25, 2012 03:44 PM

SGS Life Science Services has reopened its Fairfield, N.J. facility, having just completed a major renovation that involved doubling the size of facility, investing in new, increased laboratory space, expanded client accommodation and new equipment.

The expansion enlarges the size of the facility from 15,000 to 30,000 square feet, adding completely modernized and new GMP/GLP compliant laboratories and increases ICH Zone 1-4 storage capacities. Additionally, expanded accommodation for client audits and planning sessions were implemented as part of the design. Furthermore, SGS will invest significantly on new equipment to broaden its service offering in extractables and leachables, as well as heavy metals testing.

According to John Pirro, general manager of the Fairfield site, the facility has been designed to respond to the current and future needs of a changing bio/pharmaceutical environment. He said, "This investment will provide future capacity to service the growing needs of the bio/pharmaceutical market with expanded capabilities for stability and other project work."

Anne Hays, executive vice president, SGS, said, "With outsourcing becoming an integral part of large multinational pharmaceutical companies’ strategies, we want to assure our clients that we can accommodate both their routine and complex bio/pharmaceutical analytical outsourcing needs, integrating the latest developments in regulatory compliance."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs